Multiple Myeloma in 2023 Ways: From Trials to Real Life
Current Oncology · 2023
DOI: 10.3390/curroncol30110705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Manlio Fazio und 17 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduation School of Haematology, University of Catania, A.O.U. 'Policlinico-San Marco', 95123 Catania, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematologic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple myeloma is a chronic hematologic malignancy that obstinately tends to relapse. Basic research has made giant strides in better characterizing the molecular mechanisms of the disease. The results have led to the manufacturing of new, revolutionary drugs which have been widely tested in clinical trials. These drugs have been approved and are now part of the therapeutic armamentarium. As a consequence, it is essential to combine what we know from clinical trials with real-world data in order to improve therapeutic strategies. Starting with this premise, our review aims to describe the currently employed regimens in multiple myeloma and compare clinical trials with real-life experiences. We also intend to put a spotlight on promising therapies such as T-cell engagers and chimeric antigen receptor T-cells (CAR-T) which are proving to be effective in changing the course of advanced-stage disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Post-Graduation School of Haematology, University of Catania, A.O.U. 'Policlinico-San Marco', 95123 Catania, Italy.
- Division of Haematology and BMT, A.O.U. 'Policlinico-San Marco', 95123 Catania, Italy.
- Division of Haematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, 98125 Messina, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
- Department of Hematology I, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.
- Haematology Unit, Haemato-Oncology and Radiotherapy Department, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", 89124 Reggio Calabria, Italy.
ORCID-Profile: Manlio Fazio, Vittorio Del Fabro, Alessandro Allegra, Uroš Markovic, Cirino Botta, Fabrizio Accardi, Salvatore Leotta, Bruno Garibaldi, Alessandra Romano, Giuseppe A Palumbo, Concetta Conticello
Zitieren
APA
Fazio, M., Del Fabro, V., Parrinello, N. L., Allegra, A., Markovic, U., Botta, C., Accardi, F., Vincelli, I. D., Leotta, S., Elia, F., Esposito, B., Garibaldi, B., Sapuppo, G., Orofino, A., Romano, A., Palumbo, G. A., Di Raimondo, F., & Conticello, C. (2023). Multiple Myeloma in 2023 Ways: From Trials to Real Life. Current Oncology. https://doi.org/10.3390/curroncol30110705
Vancouver
Fazio M, Del Fabro V, Parrinello NL, Allegra A, Markovic U, Botta C, et al. Multiple Myeloma in 2023 Ways: From Trials to Real Life. Current Oncology. 2023. doi:10.3390/curroncol30110705
BibTeX
@article{Fazio2023,
author = {Fazio, Manlio and Del Fabro, Vittorio and Parrinello, Nunziatina Laura and Allegra, Alessandro and Markovic, Uroš and Botta, Cirino and Accardi, Fabrizio and Vincelli, Iolanda Donatella and Leotta, Salvatore and Elia, Federica and Esposito, Benedetta and Garibaldi, Bruno and Sapuppo, Gabriele and Orofino, Alessandra and Romano, Alessandra and Palumbo, Giuseppe A and Di Raimondo, Francesco and Conticello, Concetta},
title = {Multiple Myeloma in 2023 Ways: From Trials to Real Life},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30110705}
}
EUVIMED